Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Bad
|
New words:
academic, AI, artificial, attractive, bi, biotech, call, create, cutting, description, edge, engineered, environment, evolving, focused, immune, immunization, Importantly, increasingly, investor, jurisdiction, leading, learning, leverage, leveraged, linked, machine, mining, phenotypic, predict, Regulation, repertoire, Rule, select, sequencing, single, solution, spun, streamlined, teclistimab, terminable, terminated, termination, track, transparency, variety
Removed:
accelerated, accepted, accompanied, acquirer, administered, adult, affinity, agent, allocated, America, applied, arose, attributable, audit, began, behalf, branded, built, cancer, candidate, central, centralized, characterization, chemoradiotherapy, chemotherapy, China, choice, classical, combined, comprised, concurrent, conditional, conform, deep, default, denominated, departed, designated, disbursed, diversity, effectively, enabling, entered, Europe, exclusively, financed, forfeiture, Founder, functional, funded, generated, greatest, hand, headcount, historically, Hodgkin, holding, identified, immunomodulatory, implemented, inception, incremental, inhibitor, innovative, integration, issuing, large, leased, lieu, lung, lymphoma, maintained, managed, manner, marketable, member, met, metastatic, mission, modification, monoclonal, monotherapy, multiple, myeloma, naturally, nature, necessarily, newly, nominated, noting, office, Organization, outlined, overhead, ownership, pairing, parent, participated, past, predominant, preserve, progressed, progressing, proportionately, proteasome, pushing, rapid, ratio, rational, recapitalization, reclassified, recognize, recurrent, recycling, refractory, refund, regular, relapsed, remitted, representative, representing, retained, role, senior, sequential, shared, shown, specifically, specificity, sponsored, standalone, structure, substantially, sugemalimab, supported, systematic, taxpayer, teclistamab, therapy, treated, treatment, United, unmatched, unresectable, validated, varying, visibility, zimberelimab
Filing tables
Filing exhibits
Related press release
Associated OABI transcripts
OABI similar filings
Filing view
External links